trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['trastuzumab deruxtecan', 'destiny,breast,4', 'breast', 'destiny,breast,2', '217o']
data from the destiny-breast04 study provide additional support for the benefits of trastuzumab deruxtecan for patients with her2 low metastatic breast cancer. read more from abstract 217o presented by dr. naoto ueno: #esmo22 #endcancer 
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789